Is Mediwound Stock a Good Investment?

Mediwound Investment Advice

MDWD

To provide specific investment advice or recommendations on Mediwound stock, we recommend investors consider the following general factors when evaluating Mediwound. This will help you to make an informed decision on whether to include Mediwound in one of your diversified portfolios:

Examine Mediwound's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Mediwound's leadership team and their track record. Good management can help Mediwound navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Mediwound's business and its evolving consumer preferences.
Compare Mediwound's performance and market position to its competitors. Analyze how Mediwound is positioned in terms of product offerings, innovation, and market share.
Check if Mediwound pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Mediwound's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Mediwound stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Mediwound is a good investment.

Sell

Buy

Hold

Our investment recommendation tool can cross-verify current analyst consensus on Mediwound and to analyze the entity potential to grow in the current economic cycle. To make sure Mediwound is not overpriced, please verify all Mediwound fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that Mediwound has a price to earning of 16.58 X, we recommend you to check Mediwound market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance	Solid	Details
Volatility	Somewhat reliable	Details
Hype Condition	Stale	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Moves slightly opposite to the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Strong Buy	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Mediwound Stock

Researching Mediwound's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 26.0% of the company outstanding shares are owned by corporate insiders. The book value of Mediwound was now reported as 3.43. The company recorded a loss per share of 0.75. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022.

To determine if Mediwound is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Mediwound's research are outlined below:

	Mediwound appears to be risky and price may revert if volatility continues
	The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 13.16 M.
	Mediwound currently holds about 10.41 M in cash with (8.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
	Roughly 26.0% of the company outstanding shares are owned by corporate insiders
	Latest headline from zacks.com: Strength Seen in MediWound Can Its 14.3 percent Jump Turn into More Strength

Mediwound uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Mediwound. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mediwound's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	21st of March 2024 Upcoming Quarterly Report	View
	4th of June 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	21st of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Mediwound's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Mediwound's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2024-03-21	2023-12-31	-0.23	-0.19	0.04	17
2022-05-17	2022-03-31	-0.76	-0.84	-0.08	10
2021-05-05	2021-03-31	-0.78	-0.7	0.08	10
2023-05-30	2023-03-31	-0.3	-0.44	-0.14	46
2022-08-09	2022-06-30	-0.68	-0.84	-0.16	23
2020-11-10	2020-09-30	-0.67	-0.49	0.18	26
2020-02-25	2019-12-31	-0.73	-0.91	-0.18	24
2023-11-21	2023-09-30	-0.44	-0.24	0.2	45

Know Mediwound's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Mediwound is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mediwound backward and forwards among themselves. Mediwound's institutional investor refers to the entity that pools money to purchase Mediwound's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Essex Investment Management Company, Llc	2023-12-31	38.8 K
Meitav Dash Investments Ltd	2023-12-31	31.5 K
We Are One Seven, Llc	2023-12-31	12.2 K
Blackrock Inc	2023-12-31	11.4 K
Pathstone Holdings Llc	2023-12-31	10.9 K
Advisor Group Holdings, Inc.	2023-12-31	5 K
Pnc Financial Services Group Inc	2023-12-31	4.2 K
Morgan Stanley - Brokerage Accounts	2023-12-31	2.8 K
Advisory Services Network, Llc	2023-12-31	143
Point72 Asset Management, L.p.	2023-09-30	821.5 K
Rosalind Advisors, Inc.	2023-12-31	606.8 K

Note, although Mediwound's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mediwound's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 179.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mediwound's market, we take the total number of its shares issued and multiply it by Mediwound's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

87.08 Million

Mediwound's profitablity analysis

Mediwound's profitability indicators refer to fundamental financial ratios that showcase Mediwound's ability to generate income relative to its revenue or operating costs. If, let's say, Mediwound is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Mediwound's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Mediwound's profitability requires more research than a typical breakdown of Mediwound's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.10)	(0.11)
Return On Capital Employed	(0.28)	(0.29)
Return On Assets	(0.10)	(0.11)
Return On Equity	(0.21)	(0.22)

The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.77.

Determining Mediwound's profitability involves analyzing its financial statements and using various financial metrics to determine if Mediwound is a good buy. For example, gross profit margin measures Mediwound's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Mediwound's profitability and make more informed investment decisions.

The data published in Mediwound's official financial statements usually reflect Mediwound's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Mediwound. For example, before you start analyzing numbers published by Mediwound accountants, it's critical to develop an understanding of what Mediwound's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.

Please note, the presentation of Mediwound's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mediwound's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Mediwound's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mediwound. Please utilize our Beneish M Score to check the likelihood of Mediwound's management manipulating its earnings.

Evaluate Mediwound's management efficiency

Mediwound has return on total asset (ROA) of (0.1664) % which means that it has lost $0.1664 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.316) %, meaning that it created substantial loss on money invested by shareholders. Mediwound's management efficiency ratios could be used to measure how well Mediwound manages its routine affairs as well as how well it operates its assets and liabilities. As of May 8, 2024, Return On Tangible Assets is expected to decline to -0.11. In addition to that, Return On Capital Employed is expected to decline to -0.29. At present, Mediwound's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.14, whereas Other Assets are forecasted to decline to about 311.2 K.

	Last Reported	Projected for Next Year
Book Value Per Share	3.51	3.60
Net Current Asset Value	0.00	0.00
Tangible Asset Value	0.00	0.00
Tangible Book Value Per Share	4.34	3.34
Enterprise Value Over EBITDA	(6.08)	(6.39)
Price Book Value Ratio	2.90	2.76
Enterprise Value Multiple	(6.08)	(6.39)
Price Fair Value	2.90	2.76
Enterprise Value	86.3 M	145.2 M

The analysis of Mediwound's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Mediwound's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Mediwound Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Beta

0.926

Basic technical analysis of Mediwound Stock

As of the 8th of May, Mediwound secures the Mean Deviation of 2.93, risk adjusted performance of 0.1169, and Downside Deviation of 3.31. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mediwound, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We are able to interpolate and break down nineteen technical drivers for Mediwound, which can be compared to its peers in the industry. Please verify Mediwound treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mediwound is priced some-what accurately, providing market reflects its recent price of 18.95 per share. Given that Mediwound has jensen alpha of 0.6638, we recommend you to check Mediwound's last-minute market performance to make sure the company can sustain itself at a future point.

Understand Mediwound's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Mediwound's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.1169
	Market Risk Adjusted Performance	5.16
	Mean Deviation	2.93
	Semi Deviation	2.72
	Downside Deviation	3.31
	Coefficient Of Variation	575.57
	Standard Deviation	3.93
	Variance	15.42
	Information Ratio	0.1546
	Jensen Alpha	0.6638
	Total Risk Alpha	0.2621
	Sortino Ratio	0.1835
	Treynor Ratio	5.15
	Maximum Drawdown	21.43
	Value At Risk	(4.91)
	Potential Upside	7.19
	Downside Variance	10.94
	Semi Variance	7.38
	Expected Short fall	(3.34)
	Skewness	0.5848
	Kurtosis	1.4

	Risk Adjusted Performance	0.1169
	Market Risk Adjusted Performance	5.16
	Mean Deviation	2.93
	Semi Deviation	2.72
	Downside Deviation	3.31
	Coefficient Of Variation	575.57
	Standard Deviation	3.93
	Variance	15.42
	Information Ratio	0.1546
	Jensen Alpha	0.6638
	Total Risk Alpha	0.2621
	Sortino Ratio	0.1835
	Treynor Ratio	5.15
	Maximum Drawdown	21.43
	Value At Risk	(4.91)
	Potential Upside	7.19
	Downside Variance	10.94
	Semi Variance	7.38
	Expected Short fall	(3.34)
	Skewness	0.5848
	Kurtosis	1.4

Consider Mediwound's intraday indicators

Mediwound intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mediwound stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	982.0
	Daily Balance Of Power	0.0909
	Rate Of Daily Change	1.0
	Day Median Price	18.9
	Day Typical Price	18.91
	Price Action Indicator	0.08
	Period Momentum Indicator	0.05
	Relative Strength Index	65.29

Mediwound Corporate Filings

13A	25th of April 2024 An amended filing to the original Schedule 13G	View Verify
6K	21st of March 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
F3	1st of September 2023 An amendment to the original Schedule 13D filing	View Verify

Mediwound time-series forecasting models is one of many Mediwound's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mediwound Stock media impact

Far too much social signal, news, headlines, and media speculation about Mediwound that are available to investors today. That information is available publicly through Mediwound media outlets and privately through word of mouth or via Mediwound internal channels. However, regardless of the origin, that massive amount of Mediwound data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Mediwound news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mediwound relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mediwound's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mediwound alpha.

Mediwound Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Mediwound without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEOs Directory Now

CEOs Directory

Screen CEOs from public companies around the world

All Next

Launch Module

Mediwound Corporate Management

Elected by the shareholders, the Mediwound's board of directors comprises two types of representatives: Mediwound inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mediwound. The board's role is to monitor Mediwound's management team and ensure that shareholders' interests are well served. Mediwound's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mediwound's outside directors are responsible for providing unbiased perspectives on the board's policies.

Yaron Adv	General VP	Profile
CPA CPA	Ex Director	Profile
Ofer BSc	Chief Officer	Profile
Hani Luxenburg	Chief Officer	Profile
CWS DPM	Chief Officer	Profile

How to buy Mediwound Stock?

Examine Mediwound's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Mediwound's leadership team and their track record. Good management can help Mediwound navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Mediwound's business and its evolving consumer preferences.
Compare Mediwound's performance and market position to its competitors. Analyze how Mediwound is positioned in terms of product offerings, innovation, and market share.
Check if Mediwound pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Mediwound's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

Already Invested in Mediwound?

The danger of trading Mediwound is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mediwound is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mediwound. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mediwound is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports: